Independent Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,465
Closed -$352K 1471
2025
Q4
$352K Buy
+3,465
New +$278K 0.01% 1072
2023
Q3
Sell
-4,394
Closed -$413K 908
2023
Q2
$413K Buy
+4,394
New +$343K 0.03% 531
2022
Q2
Sell
-3,109
Closed -$217K 741
2022
Q1
$217K Hold
3,109
0.02% 709
2021
Q4
$242K Buy
3,109
+100
+3% +$8.82K 0.02% 668
2021
Q3
$287K Buy
3,009
+550
+22% +$58.1K 0.03% 539
2021
Q2
$306K Sell
2,459
-402
-14% -$48K 0.03% 527
2021
Q1
$377K Buy
2,861
+191
+7% +$26.1K 0.05% 398
2020
Q4
$354K Buy
2,670
+271
+11% +$32.8K 0.05% 383
2020
Q3
$245K Sell
2,399
-193
-7% -$16.7K 0.05% 395
2020
Q2
$225K Buy
+2,592
New +$207K 0.05% 386

Other funds holding EXAS

Independent Financial Group's EXAS Position: Q1 2026 in Review

Independent Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,465 shares — an estimated $352K sold.

Independent Financial Group first reported a position in EXAS in Q2 2020 and held it in 10 quarters. The position peaked at $413K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Independent Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Independent Financial Group sold 3,465 Exact Sciences shares in Q1 2026, an estimated $352K.
  • Independent Financial Group first reported a position in Exact Sciences in Q2 2020 and held it in 10 quarters.
  • Independent Financial Group's Exact Sciences position peaked at $413K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Independent Financial Group's 13F filing for Q1 2026, filed 5 May 2026.